{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:01:26Z","timestamp":1793314886063,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.fertnstert.2023.08.949","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T10:51:53Z","timestamp":1693047113000},"page":"945-947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["The role of uterine natural killer cells in recurrent pregnancy loss and possible treatment options"],"prefix":"10.1016","volume":"120","author":[{"given":"Yentl Louise Betty Nel","family":"B\u00e9quet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen Elisabeth Lynn O'neill","family":"Lashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariette","family":"Goddijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Louise Petronella","family":"van der Hoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2023.08.949_bib1","doi-asserted-by":"crossref","unstructured":"ESHRE Guideline Group on RPL; Bender Atik R, Christiansen OB, Elson J, Kolte AM, Lewis S, et\u00a0al. ESHRE guideline: recurrent pregnancy loss: an update in 2022. Hum Reprod Open 2023;2023:hoad002.","DOI":"10.1093\/hropen\/hoad002"},{"key":"10.1016\/j.fertnstert.2023.08.949_bib2","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1093\/humrep\/del150","article-title":"Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage","volume":"21","author":"Jauniaux","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.08.949_bib3","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","article-title":"Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2023.08.949_bib4","series-title":"The role of natural killer cells in human fertility (Scientific Impact Paper No. 53)","author":"Laird","year":"2016"},{"key":"10.1016\/j.fertnstert.2023.08.949_bib5","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3390\/biomedicines9101425","article-title":"The role of uterine natural killer cells on recurrent miscarriage and recurrent implantation failure: from pathophysiology to treatment","volume":"9","author":"Sfakianoudis","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.fertnstert.2023.08.949_bib6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nri886","article-title":"Natural killer cells and pregnancy","volume":"2","author":"Moffett-King","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.fertnstert.2023.08.949_bib7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/humupd\/dmac006","article-title":"Number and function of uterine natural killer cells in recurrent miscarriage and implantation failure: a systematic review and meta-analysis","volume":"28","author":"Von Woon","year":"2022","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2023.08.949_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1034\/j.1600-0897.2002.01048.x","article-title":"Distributions of endometrial NK cells, B cells, T cells, and Th2\/Tc2 cells fail to predict pregnancy outcome following recurrent abortion","volume":"47","author":"Michimata","year":"1989","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2023.08.949_bib9","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/humrep\/14.9.2386","article-title":"Pre-implantation endometrial leukocytes in women with recurrent miscarriage","volume":"14","author":"Quenby","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.08.949_bib10","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/humrep\/dem141","article-title":"Prognostic value of the measurement of uterine natural killer cells in the endometrium of women with recurrent miscarriage","volume":"22","author":"Tuckerman","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.08.949_bib11","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1093\/humrep\/14.11.2727","article-title":"Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study","volume":"14","author":"Clifford","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.08.949_bib12","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.4049\/jimmunol.156.10.4027","article-title":"Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome","volume":"156","author":"Lachapelle","year":"1950","journal-title":"J Immunol"},{"key":"10.1016\/j.fertnstert.2023.08.949_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/humrep\/det398","article-title":"Menstrual blood closely resembles the uterine immune micro-environment and is clearly distinct from peripheral blood","volume":"29","author":"van der Molen","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.08.949_bib14","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.fertnstert.2005.05.012","article-title":"Prednisolone reduces preconceptual endometrial natural killer cells in women with recurrent miscarriage","volume":"84","author":"Quenby","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2023.08.949_bib15","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/humrep\/det117","article-title":"A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant","volume":"28","author":"Tang","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.08.949_bib16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00404-014-3262-0","article-title":"Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial","volume":"290","author":"Gomaa","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2023.08.949_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20410","article-title":"PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages \u2013 a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation","volume":"20","author":"Coomarasamy","year":"2016","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.fertnstert.2023.08.949_bib18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1160\/TH10-05-0334","article-title":"Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial","volume":"105","author":"Visser","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2023.08.949_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00404-007-0527-x","article-title":"Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study","volume":"278","author":"Fawzy","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2023.08.949_bib20","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1093\/humrep\/dew186","article-title":"Corticosteroid therapy in assisted reproduction \u2013 immune suppression is a faulty premise","volume":"31","author":"Robertson","year":"2016","journal-title":"Hum Reprod"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028223017168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028223017168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:41:04Z","timestamp":1758012064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028223017168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0015028223017168"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2023.08.949","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of uterine natural killer cells in recurrent pregnancy loss and possible treatment options","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2023.08.949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92023 The Authors. Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}